{"id":"W3092737291","doi":"10.1016/j.cgh.2020.10.019","title":"Efficacy and Safety of Ornithine Phenylacetate for Treating Overt Hepatic Encephalopathy in a Randomized Trial","year":2020,"lang":"en","type":"article","venue":"Clinical Gastroenterology and Hepatology","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Allergan; Shire; Exelixis; Merck; AbbVie; Mallinckrodt Pharmaceuticals; Gilead Sciences; Novartis; Bayer","keywords":"Medicine; Hepatic encephalopathy; Lactulose; Placebo; Cirrhosis; Adverse effect; Gastroenterology; Internal medicine; Rifaximin; Population; Clinical endpoint; Randomized controlled trial; Liver disease; Pediatrics; Pathology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004945026,0.001837567,0.003934105,0.0005635961,0.0006426264,0.001513755,0.001008443,0.002785447,0.007730171],"category_scores_gemma":[0.004609986,0.0009167534,0.002960383,0.0005459061,0.001517009,0.001612255,0.0005928622,0.002738004,0.0009261484],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007922443,"about_ca_system_score_gemma":0.00139064,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006213931,"about_ca_topic_score_gemma":0.001208372,"domain_scores_codex":[0.9968459,0.0021966,0.000209821,0.0003598343,0.0001423326,0.0002453907],"domain_scores_gemma":[0.9968227,0.001148607,0.0008604698,0.0002600299,0.0002290079,0.000679237],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9922878,0.001728743,0.0003477412,0.0004491629,0.0007958133,0.00001905034,0.00002021179,0.00008601286,0.0004280226,0.00004572637,0.000245961,0.003545854],"study_design_scores_gemma":[0.9788828,0.01949711,0.0005694505,0.00003661642,0.0004116619,0.00001157105,0.000009460364,0.0001822385,0.0000917724,0.00007304149,0.0002277566,0.0000065205],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9567847,0.0168407,0.002057234,0.002262678,0.002068428,0.01434179,0.001919096,0.0002427025,0.003482707],"genre_scores_gemma":[0.9703034,0.004796446,0.002640377,0.002184613,0.001494018,0.01467567,0.001086555,0.00003671679,0.002782358],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007730171,"threshold_uncertainty_score":0.02615207,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03379235545656152,"score_gpt":0.3354141170480848,"score_spread":0.3016217615915233,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}